Tag: Alzheimer’s
Amyloid PET Linked to Changes in Management for MCI, Dementia
Change in management between pre-, post-PET visits for 60.2 and 63.5 percent with MCI, dementia
Ocular Protein Levels May Be Useful for Alzheimer Testing
Low levels of protein biomarkers amyloid-β and tau protein in vitreous humor tied to low cognitive scores
More Vascular Risk Factors Tied to Worse Brain Health
Most consistent associations across brain measures seen with smoking pack years, hypertension, DM
Having Affected Relatives Linked to Increased Alzheimer Risk
Increased Alzheimer disease risk seen with having affected first-, second-, or third-degree relatives
Retinal Microvascular Changes Identified in Alzheimer Disease
Changes in retinal microvasculature in superficial capillary plexus observed compared with MCI, controls
Long-Term Systemic Hormone Therapy May Up Alzheimer Risk
Risk increases associated with hormone therapy exposure over 10 years in women <60 years at initiation
Few Seniors Receive Regular Brief Cognitive Assessments
Report also reveals number of seniors living with Alzheimer disease projected to increase
FDA Warns 17 Companies About Illegal Alzheimer Disease Products
The products are often sold on websites and social media and may be ineffective, unsafe
Early Tau Deposition Elevated for Women Versus Men
Clinically normal women exhibit higher entorhinal cortical tau, which is linked to higher Aβ burden
High Levels of Activity, Motor Ability Linked to Better Cognition
Findings seen in older adults; independent correlations remained for those with Alzheimer disease
